by Annie De Groot | Dec 11, 2016 | EpiVax Immunoncology, Featured, News, Thinking Out Loud -Blog
Building on 18 years of commercially successful research and development in the field of computational immunology, EpiVax has now developed Ancer™, a personalized cancer vaccine platform. Ancer is a high-speed, secure, cloud-based commercial platform for processing...